Protein Degraders Take Industry By Storm
Proteins are essential components of living matter — they function as building blocks for cells and tissues, as well as participate in signaling and practically all biochemical activities. However, each protein operates correctly only for a limited time and is eliminated by molecular machinery after it has reached its “functional shelf life”. To maintain a healthy and functional proteome, cells tightly control protein turnover processes, ensuring that misfolded, damaged, and old proteins exit the game promptly. This sophisticated degradation mechanism was recently hijacked by the drug discovery industry to develop new small molecule therapies — protein degraders.
Topics: Novel Therapeutics